A recent study found that a 12-week supplementation with the coffee compound cafestol resulted in significant reductions in body weight and visceral fat in individuals at risk for type 2 diabetes. The study, published in Nutrients, aimed to assess the effects of pure cafestol on insulin sensitivity and glucose tolerance in healthy individuals with increased waist circumference. Results showed that cafestol did not improve glucose tolerance or insulin sensitivity but led to reductions in body weight, visceral fat volume, and gamma-glutamyl transferase levels compared to a placebo. The findings suggest that cafestol may help prevent insulin-independent diabetes, but further research is needed to explore higher doses and long-term effects.
Source link